Skip to main content
Earnings Labs
Nuvation Bio Inc. logo

Nuvation Bio Inc. (NUVB)

NYSE·Healthcare·Biotechnology

$4.91

+3.26%

Mkt Cap $1.59B

Analyst Ratings

Buy

10

Hold

1

Sell

0

Price Target (17 analysts)

$12.40

Range $10.00$17.00

Implied Upside

+152.5%

Consensus $12.40 vs current $4.91